Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
102013-72-9
13887-98-4
16024-60-5
16024-56-9
16024-58-1
16142-03-3
3064-33-3 | 4-(Decyloxy)benzohydrazide | AA00I5OH | MFCD00958293
31603-49-3 | Methyl diisopropylcarbamate | AA00I5WX | MFCD03366867
325479-50-3 | Ethyl 6-(chloromethyl)-4-(2-chlorophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | AA00I635 | MFCD00749774
330792-87-5 | 4-(Pyrimidin-2-yloxy)phenylboronic acid pinacol ester | AA00I6AY | MFCD30527673
33644-24-5 | (S)-4-(Fluoromethyl)-2,2-dimethyl-1,3-dioxolane | AA00I6JU | MFCD28397288
345-17-5 | 2-Chloro-5-fluoronitrobenzene | AA00I6QP | MFCD00084853
35294-28-1 | (R)-2,2'-Dimethoxy-1,1'-binaphthalene | AA00I6XH | MFCD00091146
36065-27-7 | N-(1-Phenyl-ethyl)-acetamide | AA00I72L | MFCD00040690
370882-66-9 | tert-Butyl (1s,5r)-3,6-diazabicyclo[3.2.0]heptane-6-carboxylate | AA00I794 | MFCD19237808
380191-00-4 | 5-(3,4-Dimethyl-phenylamino)-[1,3,4]thiadiazole-2-thiol | AA00I7EB | MFCD02720739